Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

Özet

ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, JAN 20-22, 2022

Açıklama

Anahtar kelimeler

Alıntı

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By